Organization | American Association of Endodontists

American Association of Endodontists Report issue

Foundation Phase 1 Phase 4

Organization Overview

First Clinical Trial

2013

NCT01951820

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2014

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 4 Trials (4)

articaine (Septocaine) (1 trial)

benzocaine (Orajel) (1 trial)

lidocaine (xylocaine) (1 trial)

tetracaine (pontocaine) (1 trial)

Drugs in Phase 1 Trials (3)

ciprofloxacin (cipro) (1 trial)

metronidazole (flagyl) (1 trial)

minocycline (minocin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Dental Pulp Necrosis (Phase 1)

Necrosis (Phase 1)

Overview

Highest Phase: Phase 4
# of Trials: 2
# of Trial APIs: 7